作者 |
十号文件后的一个失败了的并购案 |
![缩小字体](images/ZoomOut.gif) |
Diamondhorse
警告次数: 1
![头衔: 海归中将 头衔: 海归中将](images/342/adminleet.gif)
头衔: 海归中将 声望: 博导 性别: ![性别:男 性别:男](templates/cnphpbbice/images/icon_minigender_male.gif) 加入时间: 2005/11/01 文章: 4896
海归分: 442560
|
|
作者:Diamondhorse 在 海归商务 发贴, 来自【海归网】 http://www.haiguinet.com
在美国上市的SPAC, 特殊目的并购公司, 去年宣布与四川科伦药业合并. 但因为迟迟得不到中国方面的批准, 放弃此项并购计划. 转而兼并香港的一家公司.
有朋友说, 十号文件执行以来, 商务部还没有批过一家用股权交换形式来中国并购的案例. 以下摘自雅虎财经.
Shanghai Century Acquisition announces termination of proposed acquisition of Kelun Pharmaceutical and signing of agreements to acquire New Goal International (SHA) 7.76 : Co announced today that it has signed an agreement to terminate the share purchase agreement dated May 28, 2007 with Sichuan Kelun Pharmaceutical. At the same time, Shanghai Century announced that it has signed agreements for the acquisition of 100% of the shares of Asia Leader Investments Limited the owner of 67% of the shares of New Goal International Limited in consideration for $300,000 plus a commitment to contribute $70,000,000 to the capital of New Goal. Pursuant to these agreements Shanghai Century will also acquire Asia Leader's option to purchase the remaining 33% of New Goal, which Shanghai Century will exercise at closing for $31,800,000. This acquisition will not require PRC governmental approval since both Asia Leader and New Goal are Hong Kong companies.
作者:Diamondhorse 在 海归商务 发贴, 来自【海归网】 http://www.haiguinet.com
|
|
|
返回顶端 |
|
![](templates/cnphpbbice/images/spacer.gif) |
|
-
十号文件后的一个失败了的并购案 -- Diamondhorse - (1087 Byte) 2008-2-21 周四, 12:25 (959 reads) |
|
|
您不能在本论坛发表新主题, 不能回复主题, 不能编辑自己的文章, 不能删除自己的文章, 不能发表投票, 您 不可以 发表活动帖子在本论坛, 不能添加附件不能下载文件, |
|
|